Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis
(
- Contribution to journal › Article
-
Mark
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
(
- Contribution to journal › Article
-
Mark
Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype
(
- Contribution to journal › Article
-
Mark
Autoantibodies against methylglyoxal-modified apolipoprotein B100 and apob100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term type 1 diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
(
- Contribution to journal › Article
-
Mark
An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes
(
- Contribution to journal › Article
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
-
Mark
Orphan G-protein coupled receptor 183 (GPR183) potentiates insulin secretion and prevents glucotoxicity-induced β-cell dysfunction
(
- Contribution to journal › Article
-
Mark
The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death
(
- Contribution to journal › Article
-
Mark
Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion
(
- Contribution to journal › Article